Takeda Pharmaceutical
TAK
#497
Rank
ยฃ35.44 B
Marketcap
ยฃ10.65
Share price
0.04%
Change (1 day)
1.12%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ37.23 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are ยฃ37.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31ยฃ37.75 B-7.81%
2024-03-31ยฃ40.94 B-11.32%
2023-03-31ยฃ46.17 B-1.37%
2022-03-31ยฃ46.81 B-7.58%
2021-03-31ยฃ50.66 B-16.5%
2020-03-31ยฃ60.67 B1.89%
2019-03-31ยฃ59.54 B325.38%
2018-03-31ยฃ13.99 B-18.54%
2017-03-31ยฃ17.18 B53.16%
2016-03-31ยฃ11.21 B-4.46%
2015-03-31ยฃ11.74 B-0.42%
2014-03-31ยฃ11.79 B-1.45%
2013-03-31ยฃ11.96 B10.26%
2012-03-31ยฃ10.85 B123.23%
2011-03-31ยฃ4.86 B5.94%
2010-03-31ยฃ4.58 B-7.32%
2009-03-31ยฃ4.95 B93.13%
2008-03-31ยฃ2.56 B-3.09%
2007-03-31ยฃ2.64 B-22.38%
2006-03-31ยฃ3.40 B27.07%
2005-03-31ยฃ2.68 B-6.87%
2004-03-31ยฃ2.87 B8.76%
2003-03-31ยฃ2.64 B-7.72%
2002-03-31ยฃ2.86 B3.32%
2001-03-31ยฃ2.77 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ85.26 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ49.58 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ86.83 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ46.96 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
ยฃ0.81 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ1.52 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
ยฃ60.46 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ46.02 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ58.30 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA